Magellan Health Inc  

(Public, NASDAQ:MGLN)   Watch this stock  
Find more results for MGLN
71.23
+1.01 (1.44%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 69.68 - 71.41
52 week 45.40 - 71.88
Open 70.35
Vol / Avg. 208,456.00/198,968.00
Mkt cap 1.79B
P/E 46.31
Div/yield     -
EPS 1.54
Shares 24.76M
Beta 0.48
Inst. own 96%
Jul 29, 2016
Q2 2016 Magellan Health Inc Earnings Call - 10:00AM EDT - Add to calendar
Jul 29, 2016
Q2 2016 Magellan Health Inc Earnings Release - 9:30AM EDT - Add to calendar
Jun 15, 2016
Magellan Health Inc at Barclays Select Series Pharmacy Benefit Management & Drug Pricing Symposium
Jun 7, 2016
Magellan Health Inc at Jefferies Healthcare Conference
May 19, 2016
Magellan Health Inc Annual Shareholders Meeting (Estimated)
May 18, 2016
Magellan Health Inc Annual Shareholders Meeting
May 5, 2016
Q1 2016 Magellan Health Inc Earnings Release
May 5, 2016
Q1 2016 Magellan Health Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 1.20% 0.62%
Operating margin 2.37% 1.64%
EBITD margin - 3.88%
Return on average assets 2.60% 1.39%
Return on average equity 4.93% 2.86%
Employees 6,900 -
CDP Score - -

Address

4800 N Scottsdale Rd Ste 4400
SCOTTSDALE, AZ 85251-7680
United States - Map
+1-602-5726050 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Officers and directors

Barry Michael Smith Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Mostafa Kamal Chief Executive Officer of Magellan Rx Management
Bio & Compensation  - Reuters
Sanjeev K. Srivastava Chief Executive Officer - Magellan Healthcare
Age: 47
Bio & Compensation  - Reuters
Caskie R. Lewis-Clapper Chief Human Resource Officer
Age: 50
Bio & Compensation  - Reuters
Renie Shapiro Senior Vice President, Corporate Finance
Bio & Compensation  - Reuters
John E. Littel Senior Vice President - Government Affairs and Communications
Age: 47
Bio & Compensation  - Reuters
Srinivas Koushik Chief Technology Officer
Bio & Compensation  - Reuters
Daniel N. Gregoire General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William J. McBride Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Kay Coles James Director
Age: 66
Bio & Compensation  - Reuters